AsOf

Eli Lilly and Company · quarterly research and development2,356,500,000 United States dollar

valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted

What the statuses mean

Valid from
2023-06-30
Valid until
still holds
Published
2023-08-08
Recorded by AsOf
2026-11-08
Checked
2026-11-08 · parsed from the SEC filing
Confidence
0.95

Sources

Cite this claim

Each form names the value, its as-of date (2023-06-30), the day you read it (2026-11-09), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text
AsOf. "Eli Lilly and Company quarterly research and development: 2,356,500,000 United States dollar", as of 2023-06-30. Claim clm_A1B2A03455D9, https://asof.is/claim/clm_A1B2A03455D9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947823000221/0000059478-23-000221-index.htm.
APA
AsOf. (2023). Eli Lilly and Company quarterly research and development: 2,356,500,000 United States dollar (as of 2023-06-30) [Record clm_A1B2A03455D9]. Retrieved November 9, 2026, from https://asof.is/claim/clm_A1B2A03455D9 (source: https://www.sec.gov/Archives/edgar/data/59478/000005947823000221/0000059478-23-000221-index.htm)
BibTeX
@misc{asof_clm_A1B2A03455D9,
  author = {AsOf},
  title = {Eli Lilly and Company quarterly research and development: 2,356,500,000 United States dollar},
  year = {2023},
  howpublished = {\url{https://asof.is/claim/clm_A1B2A03455D9}},
  note = {Claim clm\_A1B2A03455D9, as of 2023-06-30; source: https://www.sec.gov/Archives/edgar/data/59478/000005947823000221/0000059478-23-000221-index.htm},
  urldate = {2026-11-09}
}

Supersedes

On the record

/claim/clm_A1B2A03455D9.md/v1/claims/clm_A1B2A03455D9submit a correction